(Registration begins at 7:15 AM)
Searle Center
Seeley G. Mudd Building (Duke University)
10 Searle Center Drive
Durham, North Carolina 27710
Hosted by:
Duke Cancer Institute
Program Overview:
This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This congress will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
Intended Audience:
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Register now for this program.
Agenda*:
| 7:15 – 8:00 AM | Registration |
| 8:00 – 8:10 AM | Welcome |
COLORECTAL CANCER |
|
| 8:10 – 8:45 AM | Treatment of Localized Rectal Cancer |
| 8:50 – 9:15 AM | Treatment of Localized Colon Cancer |
| 9:20 – 9:45 AM | Adjuvant Treatment for Colorectal Cancer |
| 9:50 – 10:10 AM | Break |
| 10:10 – 10:50 AM | Treatment of Metastatic Colorectal Cancer Al B. Benson III, MD (Invited) |
| 10:55 – 11:15 AM | NCCN Outcomes Database: Colorectal Cancer |
HEPATOCELLULAR CARCINOMA |
|
| 11:20 AM – 12:00 PM | Screening of High-Risk Patients and Surgical Options |
| 12:00 – 1:00 PM | Lunch |
| 1:00 – 1:40 PM | Selection of Systemic Therapy |
GASTRIC/ESOPHAGEAL CANCER |
|
| 1:45 – 2:30 PM | Treatment of Local Disease: A Multidisciplinary Collaboration |
| 2:35 – 3:15 PM | Management of Metastatic Disease |
| 3:15 – 3:30 PM | Break |
PANCREATIC CANCER |
|
| 3:30 – 4:10 PM | Treatment of Local Disease and Identification of High-Risk Patients |
| 4:15 – 4:55 PM | Management of Metastatic Disease |
| 4:55 – 5:00 PM | Closing Remarks |
| *Subject to change | |
Fee Information:
There is a $49 fee for this educational activity for health care providers. There is a $495 fee for industry attendees.
Accreditation Information:
This congress is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided for all sessions. Please view complete accreditation details for additional information.
Supporters:
This activity is supported by an educational donation provided by Amgen. This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Lilly USA, LLC; and Pfizer.
| Quick Links |
|
|
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0280
Copyright © 2013 National Comprehensive Cancer Network, All Rights Reserved